Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Clinical characteristics-other -
--->Nyheter
[-]Projektet
--->Sponsor
--->[-]Verkställande kommitté
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Offentlige Dokument
--->[-]Writing Committee Strategic ...
--->Dates
--->[+]Vetenskaplig granskningskom...
--->Centralkoordination
--->Språkkoordination
--->Fellowship Programme
--->[-]Constitution
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[-]Voting/Nomination
--->[-]Medlemmar
--->Request
[-]Studiesajter
--->[+]Österrike
--->[+]Belgien
--->[+]Tjeckiska republiken
--->[+]Danmark
--->[+]Finland
--->[+]Frankrike
--->[+]Tyskland
--->[+]Ireland
--->[+]Italien
--->[+]Nederländerna
--->[+]Norge
--->[+]Polen
--->[+]Portugal
--->[+]Russia
--->[-]Spanien
--->Coordination
--->HD Associations
--->Alicante
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Bilbao
--->Burgos
--->Canaries
--->Granada
--->Fuenlabrada
--->[+]Madrid-BTCIEN
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Santiago
--->Sevilla
--->Sevilla-HUVRocio
--->Sevilla-St-Ana
--->Valencia
--->Zaragoza
--->[+]Sverige
--->[+]Schweiz
--->[+]Storbritannien
--->[+]Outside Europe
[-]Arbetsgrupper
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[-]Cognitive Phenotype
--->[+]Dates
--->[-]Meetings
--->Meeting 2005/03
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Young Adults
[-]Events
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Kommunikation
--->Kontaktformulär
--->Chattrum
--->Adressregister - offentlig
--->Newsletter
--->Job Offers
datumbeskrivningstorlekförfattare dokument 
03.08.26A survey of dietary intake in patients with Huntington`s Disease32 kBanonymousapplication/mswordl03-survey-of-dietary-intake 
03.08.26Insulin sensitivity and early-phase insulin secretion in normoglycemic patients with Huntington’s Disease32 kBanonymousapplication/mswordl02-insulin-sensitivity-insulin-secret... 
03.08.26Sleep in patients with Huntington’s Disease: an interim analysis32 kBanonymousapplication/mswordl01-sleep-in-patients-with-hd 
03.08.26Assessing dysphagia in Huntington’s disease using Fiberoptic Endoscopic Evaluation of Swallowing (FEES)32 kBanonymousapplication/mswordl04-assessing-dysphagia-fees 
03.08.26Summary of carer's views of the decision to insert a percutaneous endoscopic gastrostomy (PEG) feeding tube32 kBanonymousapplication/mswordl05-summary-of-carers-views-peg 
03.08.26The Huntington’s Disease health-related Quality of Life questionnaire (HDQoL): Validation of a disease-specific measure of health-related quality of life32 kBanonymousapplication/mswordl09-validation-of-a-disease-specific-m... 
03.08.26Patient and proxy ratings using the Huntington’s Disease health-related Quality of Life questionnaire (HDQoL)32 kBanonymousapplication/mswordl08-patient-and-proxy-ratings-hdqol 
03.08.26Sexuality in Huntington´s Disease. Introducing a neuro-sexological viewpoint in bio-psycho-social rehabilitation32 kBanonymousapplication/mswordl06-sexuality-in-hd 
03.08.26Huntington's illness: the lived experience of Huntington's Disease32 kBanonymousapplication/mswordl10-the-lived-experience-of-hd 

Mapp innehåller 9 dokument.
about us | privacy statement | disclaimer | terms of use